{"disease":{"id":"smoking-cessation-assistance","name":"Smoking cessation assistance","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":7,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"bupropion","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellbutrin","generic_name":"bupropion","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"NDRI (Norepinephrine-dopamine reuptake inhibitor)","quality_score":55,"revenue":null,"mechanism":"Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects."},{"drug_id":"nicotine","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nicorette","generic_name":"NICOTINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"Cholinergic Nicotinic Agonist [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cytisine","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tabex","generic_name":"cytisine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-7","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"varenicline","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chantix","generic_name":"varenicline","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"Cholinergic Receptor Agonist","quality_score":75,"revenue":null,"mechanism":"Chantix works by activating the brain's nicotinic receptors, reducing cravings and the pleasurable effects of smoking."},{"drug_id":"wellbutrin","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Wellbutrin","company_name":"Mclean Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"champix","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Champix","company_name":"The Queen Elizabeth Hospital","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4, Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"elontril","indication_name":"Smoking cessation assistance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elontril","company_name":"Boehringer Ingelheim","drug_phase":"phase_3","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}